Global Rofecoxib Market Growth 2025-2031

December 2025 | 92 pages | ID: G096E5E500A1EN
LP Information

Abstracts

The global Rofecoxib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.

United States market for Rofecoxib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Rofecoxib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Rofecoxib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Rofecoxib players cover Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Rofecoxib Industry Forecast” looks at past sales and reviews total world Rofecoxib sales in 2024, providing a comprehensive analysis by region and market sector of projected Rofecoxib sales for 2025 through 2031. With Rofecoxib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rofecoxib industry.

This Insight Report provides a comprehensive analysis of the global Rofecoxib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rofecoxib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rofecoxib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rofecoxib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rofecoxib.

This report presents a comprehensive overview, market shares, and growth opportunities of Rofecoxib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Oral Suspension.
• Tablet-Form

Segmentation by Application:

• Osteoarthritis
• Rheumatoid Arthritis
• Juvenile Rheumatoid Arthritis
• Acute Pain Conditions
• Migraine
• Dysmenorrhea

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck
• Chengdu Meinkai Chemical Co. LTD
• Wuhan Xinxin Jiali Biotechnology Co. LTD
• Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
• Pfizer
• Tremeau

Key Questions Addressed in this Report

What is the 10-year outlook for the global Rofecoxib market?

What factors are driving Rofecoxib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Rofecoxib market opportunities vary by end market size?

How does Rofecoxib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rofecoxib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Rofecoxib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Rofecoxib by Country/Region, 2020, 2024 & 2031
2.2 Rofecoxib Segment by Type
  2.2.1 Oral Suspension.
  2.2.2 Tablet-Form
2.3 Rofecoxib Sales by Type
  2.3.1 Global Rofecoxib Sales Market Share by Type (2020-2025)
  2.3.2 Global Rofecoxib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Rofecoxib Sale Price by Type (2020-2025)
2.4 Rofecoxib Segment by Application
  2.4.1 Osteoarthritis
  2.4.2 Rheumatoid Arthritis
  2.4.3 Juvenile Rheumatoid Arthritis
  2.4.4 Acute Pain Conditions
  2.4.5 Migraine
  2.4.6 Dysmenorrhea
2.5 Rofecoxib Sales by Application
  2.5.1 Global Rofecoxib Sale Market Share by Application (2020-2025)
  2.5.2 Global Rofecoxib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Rofecoxib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Rofecoxib Breakdown Data by Company
  3.1.1 Global Rofecoxib Annual Sales by Company (2020-2025)
  3.1.2 Global Rofecoxib Sales Market Share by Company (2020-2025)
3.2 Global Rofecoxib Annual Revenue by Company (2020-2025)
  3.2.1 Global Rofecoxib Revenue by Company (2020-2025)
  3.2.2 Global Rofecoxib Revenue Market Share by Company (2020-2025)
3.3 Global Rofecoxib Sale Price by Company
3.4 Key Manufacturers Rofecoxib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Rofecoxib Product Location Distribution
  3.4.2 Players Rofecoxib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ROFECOXIB BY GEOGRAPHIC REGION

4.1 World Historic Rofecoxib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Rofecoxib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Rofecoxib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Rofecoxib Market Size by Country/Region (2020-2025)
  4.2.1 Global Rofecoxib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Rofecoxib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rofecoxib Sales Growth
4.4 APAC Rofecoxib Sales Growth
4.5 Europe Rofecoxib Sales Growth
4.6 Middle East & Africa Rofecoxib Sales Growth

5 AMERICAS

5.1 Americas Rofecoxib Sales by Country
  5.1.1 Americas Rofecoxib Sales by Country (2020-2025)
  5.1.2 Americas Rofecoxib Revenue by Country (2020-2025)
5.2 Americas Rofecoxib Sales by Type (2020-2025)
5.3 Americas Rofecoxib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Rofecoxib Sales by Region
  6.1.1 APAC Rofecoxib Sales by Region (2020-2025)
  6.1.2 APAC Rofecoxib Revenue by Region (2020-2025)
6.2 APAC Rofecoxib Sales by Type (2020-2025)
6.3 APAC Rofecoxib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Rofecoxib by Country
  7.1.1 Europe Rofecoxib Sales by Country (2020-2025)
  7.1.2 Europe Rofecoxib Revenue by Country (2020-2025)
7.2 Europe Rofecoxib Sales by Type (2020-2025)
7.3 Europe Rofecoxib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rofecoxib by Country
  8.1.1 Middle East & Africa Rofecoxib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Rofecoxib Revenue by Country (2020-2025)
8.2 Middle East & Africa Rofecoxib Sales by Type (2020-2025)
8.3 Middle East & Africa Rofecoxib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rofecoxib
10.3 Manufacturing Process Analysis of Rofecoxib
10.4 Industry Chain Structure of Rofecoxib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Rofecoxib Distributors
11.3 Rofecoxib Customer

12 WORLD FORECAST REVIEW FOR ROFECOXIB BY GEOGRAPHIC REGION

12.1 Global Rofecoxib Market Size Forecast by Region
  12.1.1 Global Rofecoxib Forecast by Region (2026-2031)
  12.1.2 Global Rofecoxib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Rofecoxib Forecast by Type (2026-2031)
12.7 Global Rofecoxib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Rofecoxib Product Portfolios and Specifications
  13.1.3 Merck Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 Chengdu Meinkai Chemical Co. LTD
  13.2.1 Chengdu Meinkai Chemical Co. LTD Company Information
  13.2.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Portfolios and Specifications
  13.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Chengdu Meinkai Chemical Co. LTD Main Business Overview
  13.2.5 Chengdu Meinkai Chemical Co. LTD Latest Developments
13.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
  13.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information
  13.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Portfolios and Specifications
  13.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Main Business Overview
  13.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Latest Developments
13.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
  13.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information
  13.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Portfolios and Specifications
  13.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Main Business Overview
  13.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Latest Developments
13.5 Pfizer
  13.5.1 Pfizer Company Information
  13.5.2 Pfizer Rofecoxib Product Portfolios and Specifications
  13.5.3 Pfizer Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Pfizer Main Business Overview
  13.5.5 Pfizer Latest Developments
13.6 Tremeau
  13.6.1 Tremeau Company Information
  13.6.2 Tremeau Rofecoxib Product Portfolios and Specifications
  13.6.3 Tremeau Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Tremeau Main Business Overview
  13.6.5 Tremeau Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Rofecoxib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Rofecoxib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral Suspension.
Table 4. Major Players ofTablet-Form
Table 5. Global Rofecoxib Sales by Type (2020-2025) & (K Units)
Table 6. Global Rofecoxib Sales Market Share by Type (2020-2025)
Table 7. Global Rofecoxib Revenue by Type (2020-2025) & ($ million)
Table 8. Global Rofecoxib Revenue Market Share by Type (2020-2025)
Table 9. Global Rofecoxib Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Rofecoxib Sale by Application (2020-2025) & (K Units)
Table 11. Global Rofecoxib Sale Market Share by Application (2020-2025)
Table 12. Global Rofecoxib Revenue by Application (2020-2025) & ($ million)
Table 13. Global Rofecoxib Revenue Market Share by Application (2020-2025)
Table 14. Global Rofecoxib Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Rofecoxib Sales by Company (2020-2025) & (K Units)
Table 16. Global Rofecoxib Sales Market Share by Company (2020-2025)
Table 17. Global Rofecoxib Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Rofecoxib Revenue Market Share by Company (2020-2025)
Table 19. Global Rofecoxib Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Rofecoxib Producing Area Distribution and Sales Area
Table 21. Players Rofecoxib Products Offered
Table 22. Rofecoxib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Rofecoxib Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Rofecoxib Sales Market Share Geographic Region (2020-2025)
Table 27. Global Rofecoxib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Rofecoxib Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Rofecoxib Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Rofecoxib Sales Market Share by Country/Region (2020-2025)
Table 31. Global Rofecoxib Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Rofecoxib Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Rofecoxib Sales by Country (2020-2025) & (K Units)
Table 34. Americas Rofecoxib Sales Market Share by Country (2020-2025)
Table 35. Americas Rofecoxib Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Rofecoxib Sales by Type (2020-2025) & (K Units)
Table 37. Americas Rofecoxib Sales by Application (2020-2025) & (K Units)
Table 38. APAC Rofecoxib Sales by Region (2020-2025) & (K Units)
Table 39. APAC Rofecoxib Sales Market Share by Region (2020-2025)
Table 40. APAC Rofecoxib Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Rofecoxib Sales by Type (2020-2025) & (K Units)
Table 42. APAC Rofecoxib Sales by Application (2020-2025) & (K Units)
Table 43. Europe Rofecoxib Sales by Country (2020-2025) & (K Units)
Table 44. Europe Rofecoxib Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Rofecoxib Sales by Type (2020-2025) & (K Units)
Table 46. Europe Rofecoxib Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Rofecoxib Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Rofecoxib Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Rofecoxib Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Rofecoxib Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Rofecoxib
Table 52. Key Market Challenges & Risks of Rofecoxib
Table 53. Key Industry Trends of Rofecoxib
Table 54. Rofecoxib Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Rofecoxib Distributors List
Table 57. Rofecoxib Customer List
Table 58. Global Rofecoxib Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Rofecoxib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Rofecoxib Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Rofecoxib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Rofecoxib Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Rofecoxib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Rofecoxib Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Rofecoxib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Rofecoxib Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Rofecoxib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Rofecoxib Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Rofecoxib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Rofecoxib Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Rofecoxib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Rofecoxib Product Portfolios and Specifications
Table 74. Merck Rofecoxib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Chengdu Meinkai Chemical Co. LTD Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 78. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Portfolios and Specifications
Table 79. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Chengdu Meinkai Chemical Co. LTD Main Business
Table 81. Chengdu Meinkai Chemical Co. LTD Latest Developments
Table 82. Wuhan Xinxin Jiali Biotechnology Co. LTD Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 83. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Portfolios and Specifications
Table 84. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Wuhan Xinxin Jiali Biotechnology Co. LTD Main Business
Table 86. Wuhan Xinxin Jiali Biotechnology Co. LTD Latest Developments
Table 87. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 88. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Portfolios and Specifications
Table 89. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Main Business
Table 91. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Latest Developments
Table 92. Pfizer Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Rofecoxib Product Portfolios and Specifications
Table 94. Pfizer Rofecoxib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Tremeau Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 98. Tremeau Rofecoxib Product Portfolios and Specifications
Table 99. Tremeau Rofecoxib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Tremeau Main Business
Table 101. Tremeau Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Rofecoxib
Figure 2. Rofecoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rofecoxib Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Rofecoxib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Rofecoxib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Rofecoxib Sales Market Share by Country/Region (2024)
Figure 10. Rofecoxib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral Suspension.
Figure 12. Product Picture ofTablet-Form
Figure 13. Global Rofecoxib Sales Market Share by Type in 2025
Figure 14. Global Rofecoxib Revenue Market Share by Type (2020-2025)
Figure 15. Rofecoxib Consumed in Osteoarthritis
Figure 16. Global Rofecoxib Market: Osteoarthritis (2020-2025) & (K Units)
Figure 17. Rofecoxib Consumed in Rheumatoid Arthritis
Figure 18. Global Rofecoxib Market: Rheumatoid Arthritis (2020-2025) & (K Units)
Figure 19. Rofecoxib Consumed in Juvenile Rheumatoid Arthritis
Figure 20. Global Rofecoxib Market: Juvenile Rheumatoid Arthritis (2020-2025) & (K Units)
Figure 21. Rofecoxib Consumed in Acute Pain Conditions
Figure 22. Global Rofecoxib Market: Acute Pain Conditions (2020-2025) & (K Units)
Figure 23. Rofecoxib Consumed in Migraine
Figure 24. Global Rofecoxib Market: Migraine (2020-2025) & (K Units)
Figure 25. Rofecoxib Consumed in Dysmenorrhea
Figure 26. Global Rofecoxib Market: Dysmenorrhea (2020-2025) & (K Units)
Figure 27. Global Rofecoxib Sale Market Share by Application (2024)
Figure 28. Global Rofecoxib Revenue Market Share by Application in 2025
Figure 29. Rofecoxib Sales by Company in 2025 (K Units)
Figure 30. Global Rofecoxib Sales Market Share by Company in 2025
Figure 31. Rofecoxib Revenue by Company in 2025 ($ millions)
Figure 32. Global Rofecoxib Revenue Market Share by Company in 2025
Figure 33. Global Rofecoxib Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Rofecoxib Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Rofecoxib Sales 2020-2025 (K Units)
Figure 36. Americas Rofecoxib Revenue 2020-2025 ($ millions)
Figure 37. APAC Rofecoxib Sales 2020-2025 (K Units)
Figure 38. APAC Rofecoxib Revenue 2020-2025 ($ millions)
Figure 39. Europe Rofecoxib Sales 2020-2025 (K Units)
Figure 40. Europe Rofecoxib Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Rofecoxib Sales 2020-2025 (K Units)
Figure 42. Middle East & Africa Rofecoxib Revenue 2020-2025 ($ millions)
Figure 43. Americas Rofecoxib Sales Market Share by Country in 2025
Figure 44. Americas Rofecoxib Revenue Market Share by Country (2020-2025)
Figure 45. Americas Rofecoxib Sales Market Share by Type (2020-2025)
Figure 46. Americas Rofecoxib Sales Market Share by Application (2020-2025)
Figure 47. United States Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Rofecoxib Sales Market Share by Region in 2025
Figure 52. APAC Rofecoxib Revenue Market Share by Region (2020-2025)
Figure 53. APAC Rofecoxib Sales Market Share by Type (2020-2025)
Figure 54. APAC Rofecoxib Sales Market Share by Application (2020-2025)
Figure 55. China Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 59. India Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Rofecoxib Sales Market Share by Country in 2025
Figure 63. Europe Rofecoxib Revenue Market Share by Country (2020-2025)
Figure 64. Europe Rofecoxib Sales Market Share by Type (2020-2025)
Figure 65. Europe Rofecoxib Sales Market Share by Application (2020-2025)
Figure 66. Germany Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 67. France Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Rofecoxib Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Rofecoxib Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Rofecoxib Sales Market Share by Application (2020-2025)
Figure 74. Egypt Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Rofecoxib Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Rofecoxib in 2025
Figure 80. Manufacturing Process Analysis of Rofecoxib
Figure 81. Industry Chain Structure of Rofecoxib
Figure 82. Channels of Distribution
Figure 83. Global Rofecoxib Sales Market Forecast by Region (2026-2031)
Figure 84. Global Rofecoxib Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Rofecoxib Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Rofecoxib Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Rofecoxib Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Rofecoxib Revenue Market Share Forecast by Application (2026-2031)